教育经历：

2013.09-2017.06                   吉林医药学院                       药学（本科）

2017.09-2020.06                     延边大学                         药学（硕士）

2020.09-2023.06    北京协和医学院 中国医学科学院药物研究所联合培养   药剂学（博士）

代表性著作：

1.Combined biomimetic MOF-RVG15 nanoformulation efficient over BBB for effective anti-glioblastoma in mice model. International Journal of Nanomedicine. 2022;17:6377-6398. （IF=8.0）

2.A Self-targeting MOFs nanoplatform for treating metastatic triple-negative breast cancer through tumor microenvironment remodeling and chemotherapy potentiation. International Journal of Pharmaceutics. 2024（accepted, IF=5.8）

3. Urea-derivative catalyzed enantioselective hydroxyalkylation of hydroxyindoles with isatins. Molecules. 2019;24(21):3944.（IF=4.4）

4. Biomimetic multifunctional nanodrugs enable regulating abnormal tumor metabolism and amplifying PDT-induced immunotherapy for synergistically enhanced tumor ablation. Materials Today. 2023; 68:125-147.（IF=24.2）

5. An EGCG-mediated self-assembled micellar complex acts as a bioactive drug carrier. Food Chemistry. 2023; 418:135939.（IF=8.8）

6. Enantioselective Friedel-Crafts reaction of indoles with N-tosylimines employing takemoto's organocatalyst. Current Organic Chemistry. 2019; 23(15) :1688-1694. (IF: 2.6)

7.一种甲氨蝶呤介导的肿瘤靶向性金属有机框架药物组合物及其制备方法及应用.中国发明专利, 202210842434.0.

8.一种RVG15 肽修饰的脑靶向性金属有机框架药物载体及其制备方法和应用.中国发明专利, 202210841737.0.

9.一种多肽二聚体修饰的前列腺癌靶向型金属有机框架药物组合物及其制备方法和应用.中国发明专利, 202211165242.7